Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Research Article Volume 5 Issue 8

Early Third Trimester Termination of Pregnancy in Case of Severe Preeclampsia with IUGR

Aklima Sultana Liza1*, Sirajun Noor Rosy2, Kawsar Sultana3 and Jahangir Alam4

1Assistant Professor, Department of Obstetrics and Gynecology, Chattogram Maa Shishu O General Hospital, Chattogram, Bangladesh
2Head of the Department of Obstetrics and Gynecology, Chattogram Maa Shishu O General Hospital, Chattogram, Bangladesh
3Lecturer, Department of Community Medicine, Chattogram Maa Shishu O General Hospital, Chattogram, Bangladesh
4Ex-Registrar, Department of Pediatrics, Chattogram Maa Shishu O General Hospital, Chattogram, Bangladesh

*Corresponding Author: Aklima Sultana Liza, Assistant Professor, Department of Obstetrics and Gynecology, Chattogram Maa Shishu O General Hospital, Chattogram, Bangladesh.

Received: June 30, 2022; Published:

×

Abstract

Pre-eclampsia is a multi-systemic disorder whose cause remains unknown and is unique to human pregnancy. It is the major culprit in many births related adverse outcomes including intrauterine growth restriction. In this study, we observed the demographics, mode of delivery and pregnancy outcome of 49 patients that were admitted to our hospital with severe pre-eclampsia and IUGR. Most common age group of study subjects were found to be between 18-25 years (n = 22) while pregnancies were usually terminated after crossing 34 weeks gestation (n = 22). More than half the patients had to undergo caesarian sections (n = 27) followed by spontaneous vaginal delivery in 19 cases. Eleven cases needed medications for termination of pregnancy using mifepristone alone (9.1%), mifepristone followed by misoprostol (63.6%); and intrauterine catheter in combination with mifepristone or misoprostol (27.3%). A minimum of four hours and a maximum of 49 hours were spent between induction of labor and the delivery of the fetus. The overall survival rate of the fetuses was 77.6%. If predicted early and managed adequately, feto-maternal morbidity and mortality can be reduced among severe cases of pregnancy with intrauterine growth restriction.

 

Keywords: Early; Third Trimester Termination; Preeclampsia; IUGR

×

References

  1. Murphy DJ and Stirrat GM. “Mortality and morbidity associated with early-onset preeclampsia”. Hypertension in Pregnancy2 (2000): 221-231.
  2. Sibai B., et al. “Pre-eclampsia”. The Lancet9461 (2005): 785-799.
  3. Crispi F., et al. “Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction”. American Journal of Obstetrics and Gynecology1 (2006): 201-207.
  4. Ness RB and Sibai BM. “Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia”. American Journal of Obstetrics and Gynecology1 (2006): 40-49.
  5. Crispi F., et al. “Predictive value of angiogenic factors and uterine artery Doppler for early‐versus late‐onset pre‐eclampsia and intrauterine growth restriction”. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology3 (2008): 303-309.
  6. Odendaal HJ and Pattinson RC. “Aggressive or Expectant Management for Patients with Severe Preeclampsia Between 28-34 weeks gestation: A Randomaized Control Trial”. Obstetrics and Gynecology 1070 (1990).
  7. Nankali A., et al. “Maternal complications associated with severe preeclampsia”. The Journal of Obstetrics and Gynecology of India2 (2013): 112-115.
  8. Witlin AG., et al. “Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24- and 33-weeks’ gestation”. American journal of obstetrics and gynecology 3 (2000): 607-611.
  9. Mylonas I and Friese K. “Indications for and risks of elective cesarean section”. Deutsches Ärzteblatt International29-30 (2015): 489.
  10. Sharma D., et al. “Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death”. Taiwanese Journal of Obstetrics and Gynecology3 (2011): 322-325.
  11. Chen W., et al. “A systematic review and network meta‐analysis comparing the use of Foley catheters, misoprostol, and dinoprostone for cervical ripening in the induction of labour”. BJOG: An International Journal of Obstetrics and Gynaecology3 (2016): 346-354.
  12. Sibai BM., et al. “Maternal and perinatal outcome of conservative management of severe preeclampsia in mid trimester”. American Journal of Obstetrics and Gynecology1 (1985): 31-37.
×

Citation

Citation: Aklima Sultana Liza., et al. “Early Third Trimester Termination of Pregnancy in Case of Severe Preeclampsia with IUGR". Acta Scientific Gastrointestinal Disorders 5.8 (2022): .




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is October 10, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US